Treating Adolescents and Young Adults (AYA) with Blood Cancer is organized by The Leukemia & Lymphoma Society (LLS).
Recorded on: October 11, 2023
This course is available from: December 12, 2023 until June 11, 2025
Description
This webinar will focus on treating adolescents and young adults (AYAs) with blood cancer, including an overview of blood cancers common in AYAs, treatment options, including new and emerging data and the role of clinical trials, and the management of short and long-term effects, as well as unique considerations for AYAs. A list of resources that you can provide to your patients, as well as additional education resources for you will also be provided.
Educational Objectives
After completing this activity, the participant should be better able to:
Accreditation, Support and Credit
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc., and The Leukemia & Lymphoma Society. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.
Social Worker Continuing Education
The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 12/10/2023-12/10/2026. Social workers completing this course receive 1.0 clinical continuing education credit.
The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #0117. LLS maintains responsibility for the program. Social workers will receive 1.0 clinical CE contact hour for this activity.
Nurse Practitioner Continuing Education
This activity is approved for 1.0 contact hour(s) of continuing education (which includes 0.25 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 23116459. This activity was planned in accordance with AANP Accreditation Standards and Policies.
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved